Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Roslan, M. Nisfu, F. R. M. Arzmi, M. H. Wahab, R. A. Zainuddin, N.

Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review

  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Domado, A. M. Adaza, H. J. F. Beltran, Apnc Buenviaje, L. M. Co, C. D. Combalicer, L. R. Corona, S. M. A. Cruz, J. B. F. Dinjotian, Macg Esperanzate, E. M. S. Luna, S. R. G. Pascua, E. J. R. Vicencio, R. R. T. Reyes, S. N.

Antibody titers of individuals vaccinated for COVID-19: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Scheffer, M. M. J. Coffeng, L. E. O'Mahony, J. F.

Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: A systematic review

  • Newborn
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Fleszar-Pavlovic, Sara E. Cameron, Linda D.

Are Interventions Efficacious at Increasing Human Papillomavirus Vaccinations Among Adults? A Meta-Analysis

  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ de Bruin, O. Phijffer, E. Ahmadizar, F. van der Maas, N. Wildenbeest, J. Sturkenboom, M. Bont, L. Bloemenkamp, K.

Are maternal vaccines effective and safe for mothers and infants? A systematic review and meta-analysis of randomised controlled trials

  • Pregnant women
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Hoang, T. N. A. Quach, H. L. Hoang, V. N. Tran, V. T. Pham, Q. T. Vogt, F.

Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Watanabe, A. Kani, R. Iwagami, M. Takagi, H. Yasuhara, J. Kuno, T.

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Jukic, I. Heffernan, A. Schelling, A. F. Kokic Males, V. Savicevic, N. J. Kovacic, V.

Association between COVID-19 Infection or Vaccination Outcomes and Methylenetetrahydrofolate Reductase Gene Polymorphism: A Systematic Review of the Literature

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fu, C. Lin, N. Zhu, J. Ye, Q.

Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review

  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Bansal, D. Kamboj, M. Anand, R. Pandiar, D. Narwal, A. Sivakumar, N. Devi, A.

Association of childhood vaccination with pediatric lichen planus: A systematic review

  • Children
  • Adolescents
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...